Clinical trial

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

NCT07516626

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2026-06-01

PhaseN/A

Study timeline

Study start (estimated)2026-06-01Date precision: month

Registry last updated2026-04-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Locally Advanced Breast Cancer (LABC)unresolved

Interventions

Sponsors & collaborators

Atlas Universitylead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07516626 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.